The European Medicines Agency (EMA) approved 200 brand new drugs between 2000 and 2010. The 161 standard medicines—not orphans—included 84 destined for long term use, by patients with asthma, for example. A review of the regulator’s public …
Get access to this article and to all of thebmj.com for 14 days.
Sign up today for a 14 day free trial.
Access to the full version of this article requires a subscription payment.